We are live on !
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow % of AUM
Cap. Flow %
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Dr. Reddy's Laboratories
RDY
$10.9B
| $584K | 0.01% |
+51,125
| New | +$542K |
2015 Q1
0 quarters
|
|
352
Credicorp
BAP
$31B
| $582K | 0.01% |
4,135
-712
| -15% | -$105K |
2014 Q1
4 quarters
|
|
353
ResMed
RMD
$33.6B
| $578K | 0.01% |
8,050
| – | – |
2013 Q2
7 quarters
|
|
354
Fifth Third Bancorp
FITB
$45.7B
| $573K | 0.01% |
30,372
+9
| +0% | +$170 |
2013 Q2
7 quarters
|
|
|
GGP
355
DELISTED
GGP Inc.
GGP
| $561K | 0.01% |
19,000
| – | – |
2013 Q2
7 quarters
|
|
356
Illumina
ILMN
$39.6B
| $557K | 0.01% |
3,084
-2,209
| -42% | -$416K |
2014 Q4
1 quarter
|
|
|
FMBI
357
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $555K | 0.01% |
31,946
| – | – |
2013 Q2
7 quarters
|
|
358
Fiserv Inc
FISV
$25.3B
| $553K | 0.01% |
13,920
-770
| -5% | -$29.4K |
2013 Q2
7 quarters
|
|
|
EXAM
359
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $552K | 0.01% |
13,265
-683
| -5% | -$27.5K |
2013 Q3
6 quarters
|
|
360
DELISTED
Newfield Exploration
NFX
| $550K | 0.01% |
15,675
-305
| -2% | -$9.24K |
2014 Q1
4 quarters
|
|
|
NPSN
361
DELISTED
NASPERS LTD
NPSN
| $547K | 0.01% |
3,545
+1,265
| +55% | +$195K |
2014 Q4
1 quarter
|
|
362
Everforth Inc
EFOR
$1.57B
| $543K | 0.01% |
14,158
+1,945
| +16% | +$70.9K |
2013 Q2
7 quarters
|
|
363
Vanguard Dividend Appreciation ETF
VIG
$113B
| $541K | 0.01% |
6,724
-1,143
| -15% | -$92.7K |
2013 Q2
7 quarters
|
|
364
Mondelez International
MDLZ
$81.6B
| $533K | 0.01% |
14,763
-453
| -3% | -$16.4K |
2013 Q2
7 quarters
|
|
365
Kaiser Aluminum
KALU
$2.41B
| $531K | 0.01% |
6,910
-390
| -5% | -$28.6K |
2014 Q2
3 quarters
|
|
366
iShares S&P India Nifty 50 Index Fund
INDY
$510M
| $530K | 0.01% |
16,925
+5,540
| +49% | +$177K |
2014 Q4
1 quarter
|
|
367
Air Products & Chemicals
APD
$66.7B
| $524K | 0.01% |
3,746
-54
| -1% | -$7.47K |
2014 Q1
4 quarters
|
|
368
Canadian Solar
CSIQ
$666M
| $524K | 0.01% |
15,680
-775
| -5% | -$21.4K |
2014 Q1
4 quarters
|
|
369
Intercontinental Exchange
ICE
$90.7B
| $522K | 0.01% |
11,190
-40
| -0.4% | -$1.8K |
2013 Q4
5 quarters
|
|
|
SGNT
370
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $518K | 0.01% |
22,261
| – | – |
2013 Q2
7 quarters
|
|
|
MHG
371
DELISTED
Marine Harvest ASA
MHG
| $515K | 0.01% |
45,165
-2,710
| -6% | -$34.7K |
2014 Q3
2 quarters
|
|
372
Ambev
ABEV
$50.7B
| $514K | 0.01% |
89,299
+20,712
| +30% | +$129K |
2013 Q4
5 quarters
|
|
373
FirstCash
FCFS
$9.34B
| $510K | 0.01% |
10,960
+4,881
| +80% | +$243K |
2014 Q1
4 quarters
|
|
374
Raymond James Financial
RJF
$30.2B
| $508K | 0.01% |
13,410
+3,675
| +38% | +$137K |
2014 Q1
4 quarters
|
|
375
DELISTED
Praxair Inc
PX
| $503K | 0.01% |
4,166
-306
| -7% | -$38.3K |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.